Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pancreatic Intraductal Neoplasms × tocotrienol, delta × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Pancreatic Intraductal Neoplasms 1

Interventions

tocotrienol, delta 1 Surgical Procedures, Operative 1 Sulindac 1 Immunohistochemistry 1 Erlotinib Hydrochloride 1 Congresses as Topic 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06519097 2025-11-13

Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡